首页> 外文OA文献 >Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with calssical antineoplastic agents

【2h】

Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with calssical antineoplastic agents

机译：依时间表依赖性增强乙基脱羟基-sparsomycin与钙性抗肿瘤药联合使用的抗肿瘤活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hofs H.P.; Wagener D.J.T.; Valk-Bakker V. de; Rennes H. van; Vos D. de; Doesburg W.H.; Ottenheijm H.C.J.; Grip W.J. de;
展开▼
作者单位

展开▼
年度 1995
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS. [J] . Furugaki K, Iwai T, Shirane M, Oncology reports . 2010,第5期

机译：与埃洛替尼和多西他赛联合使用对人非小细胞肺癌细胞具有EGFR突变，KRAS突变或野生型EGFR和KRAS的时间表依赖性抗肿瘤活性。
2. Schedule-Dependent Antitumor Activity and Toxicity of Combinations of 5-Fluorouracil and Cisplatin/Carboplatin against L1210 Leukemia-Bearing Mice [J] . Shuichi FUJIMOTO Biological & pharmaceutical bulletin . 2006,第11期

机译：附表依赖的5-氟尿嘧啶和顺铂/卡铂联合抗L1210白血病小鼠的抗肿瘤活性和毒性。
3. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo. [J] . Fujimoto S, Chikazawa H Japanese Journal of Cancer Research . 1998,第12期

机译：基于紫杉醇的联合化疗对M-109鼠肺癌的体内时间表依赖性和非依赖性抗肿瘤活性。
4. Structure-Activity Relationship Study of New FK228 Analogues as Antitumor Agents [C] . Salvatore Di Maro, Rey-Chen Pong, Jer-Tsong Hsieh American Peptide Symposium . 2009

机译：新FK228类似物作为抗肿瘤剂的结构 - 活动关系研究
5. Antifolates in combination with 5-fluorouracil and selective estrogen receptor modulators: A basis for increased antineoplastic activity and protection of bone marrow [D] . Davis, Jillian Heather. 2004

机译：抗叶酸剂与5-氟尿嘧啶和选择性雌激素受体调节剂联合使用：增加抗肿瘤活性和保护骨髓的基础
6. Antitumor Activity of HM781-36B alone or in Combination withChemotherapeutic Agents in Colorectal Cancer Cells [O] . Mi Hyun Kang, Sung Ung Moon, Ji Hea Sung, 2016

机译：HM781-36B的抗肿瘤活性单独或与下列药物合用大肠癌细胞中的化学治疗剂
7. Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS [O] . 2010

机译：与Emfr突变，KRA突变或野生型EGFR和KRA的人类非小细胞肺癌细胞中与欧洛替尼和多西紫杉醇组合的安排依赖性抗肿瘤活性。
8. Toxicity of Divided Doses of Antineoplastic Agents in Mice and Their Antineoplastic Effect in L-1210 Inoculated Mice. [R] . zendzian,robert p. teeters, winnie r. 1971

机译：抗肿瘤药物分次剂量对小鼠的毒性及其对L-1210接种小鼠的抗肿瘤作用。

Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with calssical antineoplastic agents

著录项

引文网络

相似文献

相关主题

期刊订阅